Clinical Trials
2 trialsNCT05286801 2026-05-13
Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors
National Cancer Institute (NCI)
Phase 1/2 Active not recruiting
NCT04457258 2025-08-12
68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Active not recruiting